Literature DB >> 27916171

The surgical management of esophago-gastric junctional cancer.

Joonas H Kauppila1, Jesper Lagergren2.   

Abstract

The best available surgical strategy in the treatment of resectable esophago-gastric junctional (EGJ) cancer is a controversial topic. In this review we evaluate the current literature and scientific evidence examining the surgical treatment of locally advanced EGJ cancer by comparing esophagectomy with gastrectomy, transhiatal with transthoracic esophagectomy, minimally invasive with open esophagectomy, and less extensive with more extensive lymphadenectomy. We also assess endoscopic procedures increasingly used for early EGJ cancer. The current evidence does not favor any of the techniques over the others in terms of oncological outcomes. Health-related quality of life may be better following gastrectomy compared to esophagectomy. Minimally invasive procedures might be less prone to surgical complications. Endoscopic techniques are safe and effective alternatives for early-stage EGJ cancer in the short term, but surgical treatment is the mainstay in fit patients due to the risk of lymph node metastasis. Any benefit of lymphadenectomy extending beyond local or regional nodes is uncertain. This review demonstrates the great need for well-designed clinical studies to improve the knowledge in how to optimize and standardize the surgical treatment of EGJ cancer. Crown Copyright Â
© 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardia cancer; Esophagectomy; Esophago-gastric junctional cancer; Gastrectomy; Lymphadenectomy; Surgery

Mesh:

Year:  2016        PMID: 27916171     DOI: 10.1016/j.suronc.2016.09.004

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  10 in total

1.  Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach.

Authors:  Naveena An Kumar; Ashwin Desouza; Manish S Bhandare; Jagan R Murugan; Gaurav Khandelwal; Vikram Chaudhari; Vikas Ostwal; Shailesh V Shrikhande
Journal:  Langenbecks Arch Surg       Date:  2020-11-26       Impact factor: 3.445

2.  Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival.

Authors:  Joonas H Kauppila; Karl Wahlin; Jesper Lagergren
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

3.  Outcomes of the Surgical Treatment for Adenocarcinoma of the Cardia - Single Institution Experience.

Authors:  Stojan Potrc; Arpad Ivanecz; Bojan Krebs; Urska Marolt; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

Review 4.  Current surgical treatment of esophagogastric junction adenocarcinoma.

Authors:  Shun Zhang; Hajime Orita; Tetsu Fukunaga
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

5.  Endoscopic Versus Surgical Therapy for Early Esophagogastric Junction Adenocarcinoma Based on Lymph Node Metastasis Risk: A Population-Based Analysis.

Authors:  Hua Ye; Ping Chen; Yi-Fan Wang; Xiu-Jun Cai
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

6.  Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction.

Authors:  Jia-Bin Huang; Bin-Bin Hu; Rong He; Lian He; Chen Zou; Chang-Feng Man; Yu Fan
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

7.  Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma.

Authors:  Joonas H Kauppila; Cecilia Ringborg; Asif Johar; Jesper Lagergren; Pernilla Lagergren
Journal:  Gastric Cancer       Date:  2017-08-29       Impact factor: 7.370

8.  A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort.

Authors:  Lei Huang; Zhi-Jian Wei; Tuan-Jie Li; Yu-Ming Jiang; A-Man Xu
Journal:  Oncotarget       Date:  2017-07-12

Review 9.  Surgical Treatment of Gastroesophageal Junction Cancer.

Authors:  Tadayoshi Hashimoto; Yukinori Kurokawa; Masaki Mori; Yuichiro Doki
Journal:  J Gastric Cancer       Date:  2018-09-07       Impact factor: 3.720

10.  Application value of hand-sewn anastomosis in totally laparoscopic total gastrectomy for gastric cancer.

Authors:  Zeshen Wang; Yuzhe Wei; Xirui Liu; Zhenglong Li; Guanyu Zhu; Yanfeng Li; Kuan Wang
Journal:  World J Surg Oncol       Date:  2021-08-04       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.